Kenzo has delivered a refreshing jolt to a Paris Fashion Week marked by fatigue. The fall 2025 collection under the creative direction of Nigo brought a striking mix of cultural ...

The designs unveiled on Friday were splashed with spray-paint effects. They lent an urban and tactile edge to Kenzo’s traditionally polished aesthetic.

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

Kenzo has announced that its forthcoming Paris presentation on January 25 will focus on menswear, in a break from its coed presentation style. The Nigo-led French house will expand its women’s ...